1. How and When to Decide on Revascularization in Stable Ischemic Heart Disease

3. REACH Registry Increased Risk for CV Death or MI in Patients With Stable Angina vs Risk Factors or No Angina

4. Microvascular Disease With Angina Increases Risk

5. Goals of Angina Management in Established CVD

6. IMPROVE-IT Ezetimibe + simvastatin vs simvastatin

7. Noninvasive Risk Stratification

8. Noninvasive Risk Stratification (cont)

10. Risk Stratification and Therapeutic Implications

11. Appropriateness of Invasive Testing for Diagnosis of SIHD

12. Revascularization to Improve SIHD Symptoms

14. COURAGE Revascularization vs Optimal Medical Therapy

16. Guidelines on Anti-Ischemic Medications for Symptom Relief in SIHD

17. Factors Affecting Antianginal Therapy

18. Revascularization to Improve Survival in Patients with SIHD

19. MERLIN TIMI 36 Ranolazine vs Placebo Reduces Ischemic Symptoms in Patients Undergoing PCI

20. Recurrent Angina After PCI

21. RIVER-PCI

22. Summary

23. Abbreviations

24. Abbreviations (cont)

25. References

26. References (cont)

27. References (cont)

28. References (cont)

29. References (cont)

30. References (cont)

31. References (cont)